ZURICH (Reuters) - Roche said the head of research operations at its subsidiary Genentech would retire at the end of the year, the latest in a string of executives to leave the Californian biotech unit. The Swiss firm said on Friday Richard Scheller, 61, had decided to retire as head of Genentech Research and Early Development -- known as gRED -- on Dec. 31. Michael D. Varney, who currently leads the company's small molecule drug discovery unit, will take over as head of gRED and become a member of the enlarged corporate executive committee. ...
via Health News Headlines - Yahoo News http://ift.tt/1wGy5Iq
No comments:
Post a Comment